CNTX NASDAQ
Context Therapeutics Inc.
1W: -10.4%
1M: -14.6%
3M: -51.4%
YTD: -80.0%
1Y: -68.1%
3Y: -76.0%
$0.31
-0.00 (-1.49%)
Weekly Expected Move ±8.1%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$28.5M
52W Range0.2965-3.62
Volume328,083
Avg Volume2,345,403
Beta1.69
Dividend—
Analyst Ratings
Company Info
CEOMartin A. Lehr
Employees15
SectorHealthcare
IndustryBiotechnology
IPO Date2021-10-20
Websitecontexttherapeutics.com
2001 Market Street
Philadelphia, PA 19103
US
Philadelphia, PA 19103
US
267 225 7416
About Context Therapeutics Inc.
Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. The company was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.
Latest News
BlackRock Inc. Invests $3.42 Million in Context Therapeutics Inc. $CNTX
Context Therapeutics GAAP EPS of -$0.15
Context Therapeutics Reports Second Quarter 2026 Operating and Pipeline Progress
Context Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Catalyst Watch: Micron earnings, Amazon Prime Day, and stress tests for major banks
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Kantoff Philip W. | A-Award | 45,000 | $0.58 | 2026-06-24 |
| Pasternak Andy | A-Award | 45,000 | $0.58 | 2026-06-24 |
| Stacey Jennifer Evan | A-Award | 45,000 | $0.58 | 2026-06-24 |
| West Linda | A-Award | 45,000 | $0.58 | 2026-06-24 |
| Smith Karen L. | A-Award | 45,000 | $0.58 | 2026-06-24 |